Arunjyoti Bio Ventures Share Price
4.35+0.02 (+0.46%)
-50.51% past 1 Year
Corporate filings & documents
Announcements
Change of Name of the Company from "Arunjyoti Bio Ventures Limited" to "Pasura Industries Limited"
2 weeks agoChange of Name of the Company from "Arunjyoti Bio Ventures Limited" to "Pasura Industries Limited"
2 weeks agoScrutinizer Report for 40th Annual General Meeting
1 month agoScrutinizer Report for 40th Annual General Meeting
1 month agoOutcome & Proceedings of 40th Annual General Meeting
1 month agoOutcome & Proceedings of 40th Annual General Meeting
1 month agoAnnual Report for FY 2025-26 of the Company.
2 months agoAnnual Report for FY 2025-26 of the Company.
2 months agoNotice of AGM for the FY 2025-26 scheduled to be held on 12.08.2026
2 months agoNotice of AGM for the FY 2025-26 scheduled to be held on 12.08.2026
2 months agoChanges in Management
2 months agoChanges in Management
2 months agoUn-Audited Financial Results along with Limited Review Report for the Quarter Ended 30.06.2026.
2 months agoUn-Audited Financial Results along with Limited Review Report for the Quarter Ended 30.06.2026.
2 months agoCertificate under Reg 74(5) of SEBI(DP) Regulations 2018.
2 months agoCertificate under Reg 74(5) of SEBI(DP) Regulations 2018.
2 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and approve 1. Un-audited Financial Results along with Limited Review Report for the Quarter ended 30.06.2026.2. Any other business with the permission of the chair.
2 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and approve 1. Un-audited Financial Results along with Limited Review Report for the Quarter ended 30.06.2026.2. Any other business with the permission of the chair.
2 months agoClosure of Trading Window for Un-audited Financial Results for the Quarter ending 30.06.2026.
2 months agoClosure of Trading Window for Un-audited Financial Results for the Quarter ending 30.06.2026.
2 months agoAnnual Secretarial Compliance Report for the FY ended 31.03.2026
3 months agoNewspaper Publication for the Audited Financial Results for the Quarter and year ended 31.03.2026
4 months agoAudited Financial Statements for the Quarter and Year ended 31.03.2026
4 months agoAudited Financial Statements for the Quarter and Year ended 31.03.2026
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026.
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year ended 31.03.2026.
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financials results for the Quarter and Year ended 31.03.2026.
4 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financials results for the Quarter and Year ended 31.03.2026.
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Arunjyoti Bio Ventures Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L01400TG1986PLC062463</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Swati Jain</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Vishal Nadimpalli</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Arunjyoti Bio Ventures Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L01400TG1986PLC062463</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Swati Jain</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Vishal Nadimpalli</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Arunjyoti Bio Ventures Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L01400TG1986PLC062463</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>20.57</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Swati Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vishal Nadimpalli <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Arunjyoti Bio Ventures Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L01400TG1986PLC062463</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>20.57</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Swati Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vishal Nadimpalli <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Chennupati Sarath Kumar
5 months agoClarification in trading of the shares of the Company.
5 months agoClarification in trading of the shares of the Company.
5 months agoCompliance Certificate under SEBI (DP) Regulations 2018
5 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Chennupati Sarath Kumar
5 months agoClosure of Trading Window
5 months agoClosure of Trading Window
5 months agoIntimation of Installation and commisioning of New Jelly Pouch Production Line
6 months agoUnauited Financial Results along with Limited Review Report for the quarter ended 31.12.2025
7 months agoApproval of Un-audited financial results along with the Limited Review Report for the quarter ended 31.12.2025
7 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Un-audited financial results along with Limited Review Report for the quarter ended 31.12.2025 and any other business with the permission of the Chair.
7 months agoCompliance Certificate
8 months agoClosure of trading window
8 months agoOutcome
10 months agoArunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve Un-audited Financial Results for the quarter ended 30.09.2025
10 months agoCertificate u/r. 75(5)
11 months agoAnnual reports
Concalls & investor presentations
No presentations found